Japanese research-driven pharmaceutical company Shionogi & Co., Ltd., on 24 June 2019, announces that the Company ha...
Ricoh Company, Ltd., (Tokyo, Japan) has announced it has entered into a strategic business partnership with Elixirgen Sc...
Japan headquartered Toray has announced that a small size of TORAYMYXINTM (PMX-05R) had obtained EC certificate and is l...
Myriad Genetic Laboratories, a wholly-owned subsidiary of Myriad Genetics has announced the Japanese Ministry...
Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan has announced ...
Ricoh Company has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc. to deve...
Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrec...
Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYT...
Catalys Pacific, a new venture capital firm in Japan built by a global team seasoned in life sciences investin...
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has ...
Japan headquartered Terumo Corporation, a leading global medical device manufacturer has announced that it has secured e...
BiomX Ltd., a microbiome company developing both natural and engineered phage therapies has announced it has licensed a ...
Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...
Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...
Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that...
Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative...
Japan headquartered FUJIFILM Corporation has announced an initial $10M USD investment to establish a...
Takeda Pharmaceutical Company Limited has announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with...
